CN111500751A - Detection method and kit for rapidly detecting high-toxicity Klebsiella pneumoniae - Google Patents
Detection method and kit for rapidly detecting high-toxicity Klebsiella pneumoniae Download PDFInfo
- Publication number
- CN111500751A CN111500751A CN202010278740.7A CN202010278740A CN111500751A CN 111500751 A CN111500751 A CN 111500751A CN 202010278740 A CN202010278740 A CN 202010278740A CN 111500751 A CN111500751 A CN 111500751A
- Authority
- CN
- China
- Prior art keywords
- primer
- klebsiella pneumoniae
- reaction
- follows
- upstream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000588747 Klebsiella pneumoniae Species 0.000 title claims abstract description 79
- 231100000086 high toxicity Toxicity 0.000 title claims abstract description 46
- 238000001514 detection method Methods 0.000 title claims abstract description 40
- 238000006243 chemical reaction Methods 0.000 claims abstract description 87
- 238000000034 method Methods 0.000 claims abstract description 40
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 39
- 230000003321 amplification Effects 0.000 claims abstract description 31
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 31
- 239000000243 solution Substances 0.000 claims description 27
- 230000001018 virulence Effects 0.000 claims description 21
- 239000012295 chemical reaction liquid Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 13
- 239000011259 mixed solution Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 7
- 229920001817 Agar Polymers 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 6
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 6
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- 229960003237 betaine Drugs 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- 239000008223 sterile water Substances 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000012154 double-distilled water Substances 0.000 claims description 3
- 238000001917 fluorescence detection Methods 0.000 claims description 3
- 238000007790 scraping Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000012360 testing method Methods 0.000 description 16
- 230000035945 sensitivity Effects 0.000 description 13
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000001962 electrophoresis Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 6
- 206010024652 Liver abscess Diseases 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 206010040047 Sepsis Diseases 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 239000012160 loading buffer Substances 0.000 description 4
- 238000007397 LAMP assay Methods 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 206010014801 endophthalmitis Diseases 0.000 description 3
- 238000011901 isothermal amplification Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 208000013223 septicemia Diseases 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 208000031729 Bacteremia Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000037041 Community-Acquired Infections Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010057192 Muscle and soft tissue infections Diseases 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 208000037815 bloodstream infection Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 208000026426 spleen abscess Diseases 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000004227 thermal cracking Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005491 wire drawing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a detection method and a kit for rapidly detecting high-toxicity Klebsiella pneumoniae, wherein the method comprises the steps of extracting strain DNA, placing the extracted strain DNA and primers in a reaction solution for L AMP amplification reaction, wherein the reaction solution contains a guide, and the primers comprise an upstream outer primer F3: 5'-TGGGGTTATTCTTTCGCT-3', a downstream outer primer B3: 5'-TTTCCAAGCTTACTGCAATT-3', an upstream inner primer FIP 5 '-CCagCAAAacAGCCTAAATACATTG-TGGGGAGTATCTTTGAGAGG-3', a downstream inner primer BIP 5 '-TTGGGATACTGTGCTATTTTTCTCT-GGGAAGATGAGAAATACGAGC-3', an upstream loop primer L F5'-CGCCTCCGTGATGAGGATG-3', a downstream loop primer L B5'-GCAGAAAAGGGCTAGCGC-3' and L AMP amplification reaction is finished, and then detecting the reaction solution to judge whether high-toxicity Klebsiella pneumoniae exists.
Description
Technical Field
The invention relates to the technical field of microbial detection, in particular to a detection method and a kit for rapidly detecting high-toxicity Klebsiella pneumoniae.
Background
Klebsiella pneumoniae is a common pathogenic bacterium for community-acquired infections and hospital-acquired infections. The klebsiella pneumoniae has thick capsular polysaccharide and can effectively inhibit phagocytosis of neutrophils and the action of antibiotics, so that pneumonia, bloodstream infection, urinary tract infection and the like are more easily caused. Currently, with the difference of capsular polysaccharide types and the change of bacterial virulence, the infection caused by the high-virulence strain of Klebsiella pneumoniae becomes a worldwide infectious disease. Compared with classical Klebsiella pneumoniae (cKP) acquired in hospitals, the death rate of the HvKP infected vaccine is high, and severe complications such as sepsis and migratory infection are accompanied. In recent years, the drug resistance of hvKP bacteria and the relationship with bacterial adaptability/virulence have received worldwide attention. Particularly, the emergence of carbapenem drug-resistant hvKP (CR-hvKP) bacteria brings serious challenges to clinical treatment and basic research.
High-toxicity klebsiella pneumoniae is a common community-acquired and hospital-infected pathogen, can cause disseminated infections such as liver abscess, endophthalmitis and septicemia, is mostly related to serotyping and high-mucus phenotype of K1 and K2 capsules, and is often defined as high-toxicity klebsiella pneumoniae (hvKP). In recent 30 years, it has been found that klebsiella pneumoniae has gradually become the main pathogen of bacterial liver abscess, especially klebsiella pneumoniae with high toxicity, which is more common and is spreading as a new invasive syndrome. hvKP has strong invasiveness and biofilm formation ability, and the resulting infections include abdominal diseases (community-acquired liver abscess, spleen abscess, idiopathic peritonitis), chest diseases (pneumonia, empyema), endophthalmitis, central nervous system diseases (meningitis), skeletal muscle and soft tissue infections, urinary tract infections, mixed infections, bacteremia, among which community-acquired liver abscess are the most common.
The detection of the high-toxicity Klebsiella pneumoniae is an important means for judging the pathogenic causes of disseminated infection such as liver abscess, endophthalmitis, septicemia and the like. The traditional method for detecting high-toxicity Klebsiella pneumoniae comprises colony morphology, wiredrawing test, nematode test, neutrophil phagocytosis resistance test, serum resistance test and the like, and the methods are long in time consumption, cannot report clinic quickly and are easy to delay the disease condition. In addition, the traditional method has low detection sensitivity and weak specificity, and is difficult to distinguish by physiological and biochemical methods especially for strains with similar sources. Although bacteria can be quickly identified by applying the traditional PCR (Polymerase Chain Reaction), the traditional PCR method has expensive equipment, complex steps, high requirements on personnel and difficulty in large-area popularization.
The loop-mediated isothermal amplification technology (L oop-mediated isothermal amplification, L AMP) is a novel nucleic acid in-vitro amplification technology under a constant temperature condition, and has the characteristics of isothermality, rapidness, high specificity, high sensitivity, simple and convenient product detection and the like.
Disclosure of Invention
The present invention is directed to solving, at least to some extent, one of the technical problems in the related art. Therefore, the first purpose of the invention is to provide a detection method for rapidly detecting high-toxicity Klebsiella pneumoniae.
The second purpose of the invention is to provide a detection kit for rapidly detecting high-toxicity Klebsiella pneumoniae.
In order to achieve the above object, in a first aspect, a detection method for rapidly detecting high virulence klebsiella pneumoniae according to an embodiment of the invention includes the steps of:
extracting strain DNA;
placing the extracted strain DNA and the primer into a reaction solution to carry out L AMP amplification reaction;
the reaction solution comprises a primer, and the primer comprises:
the upstream outer primer F3: 5'-TGGGGTTATTCTTTCGCT-3', respectively;
downstream outer primer B3: 5'-TTTCCAAGCTTACTGCAATT-3', respectively;
an upstream inner primer FIP: 5 '-CCagCAAAacAGCCTAAATACATTG-TGGGGAGTATCTTTGAGAGG-3';
the downstream inner primer BIP: 5 '-TTGGGATACTGTGCTATTTTTCTCT-GGGAAGATGAGAAATACGAGC-3';
an upstream loop primer L F: 5'-CGCCTCCGTGATGAGGATG-3';
downstream loop primer L B: 5'-GCAGAAAAGGGCTAGCGC-3';
l after the AMP amplification reaction is finished, the reaction solution is tested to determine whether there is Klebsiella pneumoniae with high toxicity.
Further, according to an embodiment of the present invention, the method for extracting DNA from a strain comprises:
experimental bacteria were inoculated on MH agar plates and cultured overnight in an incubator at 37 ℃;
scraping appropriate amount of bacteria from MH agar plate, placing in 500ul of EP tube containing autoclaved double distilled water, and boiling in water bath for 10 min;
cooling in refrigerator for 10 min;
centrifuging at 12000g for 10min at 4 deg.C, and collecting supernatant.
Further, according to an embodiment of the present invention, the mixed solution of the reaction solution is configured to:
12.5 μ L2 × HNB L AMP;
2.5 μ L10 ×L AMP primer mix;
0.8M betaine;
1.0 μ L Bst DNA polymerase;
1 μ L template DNA;
25 μ L sterile water.
Further, according to an embodiment of the present invention, the 2.5 μ L10 ×L AMP primer mixture concentration is configured as:
the concentrations of the upstream outer primer F3 and the downstream outer primer B3 are respectively as follows: 0.5 uM;
the concentrations of the upstream inner primer FIP and the downstream inner primer BIP are respectively as follows: 8 uM;
the concentration of the upstream loop primer L F and the downstream loop primer L B was 2uM, respectively.
Further, according to one embodiment of the present invention, the reaction conditions of the L AMP amplification reaction are:
placing the mixed solution of L AMP amplification reaction in a water bath environment;
the reaction temperature is as follows: a gradient is formed at every 5 ℃ between 55 and 85 ℃;
the reaction time is as follows: and gradient every 5min for 40-70 min.
Further, according to an embodiment of the present invention, the reaction conditions of the L AMP amplification reaction are specifically:
the reaction temperature is as follows: 65 ℃;
the reaction time is as follows: 60 min;
the termination reaction temperature was: 85 ℃;
the reaction termination time was: and 5 min.
Further, according to an embodiment of the present invention, the detecting the reaction result to determine whether there is klebsiella pneumoniae with high virulence includes:
taking reaction liquid, detecting a PCR amplification result by using agarose gel electrophoresis, if a gradient band is positioned and the minimum band is 180bp, indicating that the Klebsiella pneumoniae with high toxicity exists, and if not, indicating that the Klebsiella pneumoniae with high toxicity does not exist;
or adding SYBR green I into the reaction liquid for fluorescence detection, if the reaction liquid is green, indicating that the high-toxicity Klebsiella pneumoniae exists, otherwise, indicating that the high-toxicity Klebsiella pneumoniae does not exist.
On the other hand, the invention also provides a detection kit for rapidly detecting the high-toxicity Klebsiella pneumoniae, which comprises:
l AMP amplification reaction liquid, wherein the L AMP amplification reaction liquid contains primers which are respectively:
the upstream outer primer F3: 5'-TGGGGTTATTCTTTCGCT-3', respectively;
downstream outer primer B3: 5'-TTTCCAAGCTTACTGCAATT-3', respectively;
an upstream inner primer FIP: 5 '-CCagCAAAacAGCCTAAATACATTG-TGGGGAGTATCTTTGAGAGG-3';
the downstream inner primer BIP: 5 '-TTGGGATACTGTGCTATTTTTCTCT-GGGAAGATGAGAAATACGAGC-3';
an upstream loop primer L F: 5'-CGCCTCCGTGATGAGGATG-3';
the downstream loop primer L B: 5'-GCAGAAAAGGGCTAGCGC-3'.
Further, according to an embodiment of the present invention, the mixed solution of the reaction solution is configured such that:
12.5 μ L2 × HNB L AMP;
2.5 μ L10 ×L AMP primer mix;
0.8M betaine;
1.0 μ L Bst DNA polymerase;
1 μ L template DNA;
25 μ L sterile water.
Further, according to an embodiment of the present invention, the 2.5 μ L10 ×L AMP primer mixture concentration is configured as:
the concentrations of the upstream outer primer F3 and the downstream outer primer B3 are respectively as follows: 0.5 uM;
the concentrations of the upstream inner primer FIP and the downstream inner primer BIP are respectively as follows: 8 uM;
the concentration of the upstream loop primer L F and the downstream loop primer L B was 2uM, respectively.
In addition, the specific primers designed for the peg-344 gene of the high-toxicity Klebsiella pneumoniae are optimized under conditions, results can be obtained within 60min at 65 ℃, electrophoresis detection is not needed, the operation is simple and convenient, the result judgment is simple, and the detection cost is reduced, the lowest detection limit of the L AMP reaction system for the high-toxicity Klebsiella pneumoniae to a genome is 0.475/mu L, the sensitivity is 100 times higher than that of the traditional PCR method, the detection sensitivity is improved, and the specific characteristics are better.
In addition, the establishment of the method provided by the embodiment of the invention can quickly detect the high-toxicity Klebsiella pneumoniae, so that the technology is worthy of further popularization in the primary medical unit, can also be used as a quick primary screening test for monitoring the catering industry environment and food safety by the primary epidemic prevention department, and has important significance in epidemiology.
Additional aspects and advantages of the invention will be set forth in part in the description which follows and, in part, will be obvious from the description, or may be learned by practice of the invention.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the structures shown in the drawings without creative efforts.
FIG. 1 is a flow chart of a detection method for rapidly detecting Klebsiella pneumoniae with high virulence according to an embodiment of the present invention;
FIG. 2 is a flow chart of a method for extracting DNA from a strain according to an embodiment of the present invention;
FIG. 3 is a flowchart of another method for rapidly detecting Klebsiella pneumoniae with high virulence according to the embodiment of the present invention;
FIG. 4 is a flowchart of another method for rapidly detecting Klebsiella pneumoniae with high virulence according to the embodiment of the present invention;
FIG. 5 shows the result of detection of L AMP after amplification reaction in 2% agarose gel;
FIG. 6 is a graph showing the results of a sensitivity test of the L AMP method provided in an example of the present invention;
FIG. 7 is a diagram showing the results of gel electrophoresis results of the L AMP method for detecting the products of loop-mediated isothermal amplification of Klebsiella pneumoniae template DNA according to the embodiment of the present invention;
FIG. 8 shows the result of gel electrophoresis of the L AMP method to detect the high-virulence Klebsiella pneumoniae template DNA loop-mediated isothermal amplification products of different strains according to the embodiment of the invention;
the implementation, functional features and advantages of the objects of the present invention will be further explained with reference to the accompanying drawings.
Detailed Description
The present invention will be further explained with reference to the following examples. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. The following examples do not indicate specific conditions as experimental methods, and the strains referred to in the examples are generally known in the art and readily available from published commercial sources to those skilled in the art, according to the conditions in the conventional practice or according to the manufacturer's recommendations.
In one aspect, the invention provides a detection method for rapidly detecting high-toxicity klebsiella pneumoniae, which comprises the following steps: s101, extracting strain DNA.
S102, placing the extracted strain DNA and the primers into a reaction solution to carry out L AMP amplification reaction.
Upstream outer primer F3(5 '→ 3'): TGGGGTTATTCTTTCGCT are provided.
Downstream outer primer B3(5 '→ 3'): TTTCCAAGCTTACTGCAATT are provided.
Upstream inner primer FIP (5 '→ 3'): CCagCAAAacAGCCTAAATACATTG-TGGGGAGTATCTTTGAGAGG.
Downstream inner primer BIP (5 '→ 3'): TTGGGATACTGTGCTATTTTTCTCT-GGGAAGATGAGAAATACGAGC.
The upstream loop primer L F (5 '→ 3'): CGCCTCCGTGATGAGGATG.
The downstream loop primer L B (5 '→ 3'): GCAGAAAAGGGCTAGCGC.
S103 and L, detecting a reaction solution after the AMP amplification reaction is finished to judge whether high-toxicity Klebsiella pneumoniae exists, wherein the reaction solution contains a guide substance, and the primers are respectively as follows:
specifically, in step S101, a strain DNA is extracted by a thermal cracking method, in the embodiment of the present invention, a specific gene peg-344 of klebsiella pneumoniae with high virulence is selected as a target gene and a primer set is designed, and in step S102, the strain DNA and the primer set are placed in a L AMP reaction system to perform an amplification reaction of L AMP (L oop-mediated isothermal amplification technique), after the diffusion reaction, the diffusion reaction result is observed in step S103 to determine whether klebsiella pneumoniae with high virulence is contained in the extracted strain DNA.
In addition, the embodiment of the invention designs specific primers aiming at the specific gene peg-344 gene of the high toxicity Klebsiella pneumoniae, can obtain results within 60min at 65 ℃ through condition optimization without electrophoresis detection, can directly observe by fluorescence, is simple and convenient to operate, has simple result judgment and reduces the detection cost, and the lowest detection limit of the high toxicity Klebsiella pneumoniae L AMP reaction system on a genome is 0.475 pg/mu L, has 100 times higher sensitivity than that of the traditional PCR method, improves the detection sensitivity, and has better specificity characteristics.
In addition, the establishment of the method provided by the embodiment of the invention can quickly detect the high-toxicity Klebsiella pneumoniae, so that the technology is worthy of further popularization in the primary medical unit, can also be used as a quick primary screening test for monitoring the catering industry environment and food safety by the primary epidemic prevention department, and has important significance in epidemiology.
Further, in one embodiment of the present invention, the method for extracting DNA from a strain comprises the steps of: s201, experimental bacteria were inoculated on MH agar plates and cultured in an incubator at 37 ℃ overnight.
S202, scraping a proper amount of bacteria from an MH agar plate, placing the bacteria in an EP tube of 500ul of autoclaved double distilled water, and carrying out boiling water bath for 10 min.
And S203, cooling in a refrigerator for 10 min.
S204, centrifuging at 12000g for 10min at the temperature of 4 ℃, and taking supernatant.
Specifically, the preparation of the PCR template strain DNA can be completed through steps S201 to S204, and the whole operation process is aseptic operation.
Further, in a preferred embodiment of the present invention, the mixed solution of the reaction solution is configured such that:
12.5 μ L2 × HNB L AMP.
2.5 μ L10 ×L AMP primer mix.
0.8M betaine.
1.0 μ L Bst DNA polymerase.
1 μ L template DNA.
25 μ L sterile water.
The L AMP reaction satisfies preferable reaction conditions by preparing a mixed solution of the reaction solution.
Further, in a preferred embodiment of the present invention, the concentration of the 2.5 μ L10 ×L AMP primer mixture is configured as follows:
the concentrations of the upstream outer primer F3 and the downstream outer primer B3 are respectively as follows: 0.5 uM.
The concentrations of the upstream inner primer FIP and the downstream inner primer BIP are respectively as follows: 8 uM.
The concentration of the upstream loop primer L F and the downstream loop primer L B was 2uM, respectively.
The L AMP reaction satisfies preferable reaction conditions by preparing a mixed solution of the reaction solution.
Further, in a preferred embodiment of the present invention, the reaction conditions for the L AMP amplification reaction are:
placing the mixed solution of L AMP amplification reaction in a water bath environment;
the reaction temperature is as follows: a gradient is formed at every 5 ℃ between 55 and 85 ℃;
the reaction time is 40-70 min, and a gradient is formed every 5min, so that the L AMP reaction meets the better reaction condition through the reaction temperature and time condition of the mixed solution of the reaction liquid.
Further, in a preferred embodiment of the present invention, the reaction conditions of the L AMP amplification reaction are specifically:
the reaction temperature is as follows: and 65 ℃.
The reaction time is as follows: and (5) 60 min.
The termination reaction temperature was: 85 ℃.
The reaction termination time was: and 5 min.
The L AMP reaction satisfies preferable reaction conditions by the conditions of the reaction temperature and time of the liquid mixture of the reaction solution.
The step of detecting the reaction result to judge whether the high-toxicity Klebsiella pneumoniae exists comprises the following steps:
s303, taking reaction liquid, detecting a PCR amplification result by using agarose gel electrophoresis, wherein if a gradient band is positioned and the minimum band is 180bp, the existence of the Klebsiella pneumoniae with high toxicity is indicated, and otherwise, the existence of the Klebsiella pneumoniae with high toxicity is not indicated; or adding SYBR green I into the reaction liquid for fluorescence detection, if the reaction liquid is green, indicating that the high-toxicity Klebsiella pneumoniae exists, otherwise, indicating that the high-toxicity Klebsiella pneumoniae does not exist.
When the reaction solution is taken out and the PCR amplification result is detected by agarose gel electrophoresis, the method comprises the following steps:
s403, mixing the stress solution with a 10 ×L-loading buffer, adding the mixture into a sample loading hole of agarose gel, carrying out electrophoresis at 120V for 20min, taking out a gel block, and obtaining a PCR amplification result through an electrophoresis strip in an ultraviolet imaging system, wherein if a gradient strip is positioned and the minimum strip is 180bp, the existence of high-toxicity Klebsiella pneumoniae is indicated, and otherwise, the existence of no high-toxicity Klebsiella pneumoniae is indicated.
Further, in one embodiment of the invention, the content of the liquid for releasing is 0.5u L.
The 10 ×L loading buffer is 4.5u L.
The removed aliquot was mixed with a 10 ×L loading buffer and added to the loading well of a 2% agarose gel.
Specifically, in steps S203 and S303, after the L AMP reaction is finished, (1) 0.5 mu L of reaction liquid is sucked by a gun head, mixed with 4.5 mu L10 ×L of loading buffer and added into a loading hole of 2% agarose gel, electrophoresis is carried out for 20min at 120V, a gel block is taken out, an electrophoresis strip is observed in an ultraviolet imaging system, photographing is carried out for recording, and the specific standard for determining whether the target bacteria exist in the sample is that the PCR amplification result is detected by the agarose gel electrophoresis, and if a gradient strip exists, and the minimum strip is 180bp, the existence of the high-toxicity Klebsiella pneumoniae is indicated.
(2) Adding 1 mu L SYBR green I dye into the reaction liquid, and determining whether the target bacteria exist in the sample according to the specific standard that if the reaction liquid is green, the existence of the high-toxicity Klebsiella pneumoniae is indicated.
Referring to fig. 5, a comparison graph of L AMP amplification results is shown, where P is a positive control, N is a negative control, (a) P appears green after SYBR green I is added under natural illumination conditions, N appears yellowish, (B) P appears bright green after SYBR green I is added under ultraviolet illumination conditions, N appears yellowish, (C) (as in fig. 5) appears a stepped band after 2% agarose gel electrophoresis, and N has no band at all, it can be known from the comparison of fig. 5 and fig. 5 that the detection method for rapidly detecting klebsiella pneumoniae with high virulence can realize rapid detection and judgment of klebsiella pneumoniae with high virulence of pneumonia.
On the other hand, the invention also provides a detection kit for rapidly detecting the high-toxicity Klebsiella pneumoniae, which comprises L AMP amplification reaction liquid, wherein the L AMP amplification reaction liquid comprises primers which are respectively:
upstream outer primer F3(5 '→ 3'): TGGGGTTATTCTTTCGCT are provided.
Downstream outer primer B3(5 '→ 3'): TTTCCAAGCTTACTGCAATT are provided.
Upstream inner primer FIP (5 '→ 3'):
CCagCAAAacAGCCTAAATACATTG-TGGGGAGTATCTTTGAGAGG。
downstream inner primer BIP (5 '→ 3'):
TTGGGATACTGTGCTATTTTTCTCT-GGGAAGATGAGAAATACGAGC。
the upstream loop primer L F (5 '→ 3'): CGCCTCCGTGATGAGGATG.
The downstream loop primer L B (5 '→ 3'): GCAGAAAAGGGCTAGCGC.
In addition, the embodiment of the invention designs specific primers aiming at the peg-344 gene of the specific gene of the Klebsiella pneumoniae with high toxicity, can obtain results within 60min at 65 ℃ by condition optimization without electrophoretic detection, can directly observe by fluorescence, is simple and convenient to operate, has simple result judgment and reduces the detection cost, and the minimum detection limit of the Klebsiella pneumoniae L AMP reaction system on a genome is 0.475 pg/mu L, has 100 times higher sensitivity than that of the traditional PCR method, improves the detection sensitivity and has better specificity characteristics.
In addition, the kit provided by the embodiment of the invention can be used for quickly detecting the high-toxicity Klebsiella pneumoniae, so that the technology is worthy of further popularization in the primary medical unit, can also be used as a quick primary screening test for monitoring the catering industry environment and food safety in the primary epidemic prevention department, and has important significance in epidemiology.
Further, in one embodiment of the present invention, the mixed solution of the reaction solution is configured to:
12.5 μ L2 × HNB L AMP.
2.5 μ L10 ×L AMP primer mix.
0.8M betaine.
1.0 μ L Bst DNA polymerase.
1 μ L template DNA.
25 μ L sterile water.
The L AMP reaction satisfies preferable reaction conditions by preparing a mixed solution of the reaction solution.
Further, in an embodiment of the present invention, the concentration of the 2.5 μ L10 ×L AMP primer mixture is configured as follows:
the concentrations of the upstream outer primer F3 and the downstream outer primer B3 are respectively as follows: 0.5 uM.
The concentrations of the upstream inner primer FIP and the downstream inner primer BIP are respectively as follows: 8 uM.
The concentration of the upstream loop primer L F and the downstream loop primer L B was 2uM, respectively.
The L AMP reaction satisfies preferable reaction conditions by preparing a mixed solution of the reaction solution.
The sensitivity test result of the L AMP method provided by the embodiment of the invention is as follows:
referring to FIG. 6, a graph of the sensitivity test results of the L AMP method provided by the embodiments of the present invention is obtained by measuring the initial concentration of Klebsiella pneumoniae genome, which is 475 ng/. mu. L, by using the Take3 program of a microplate spectrophotometer, subjecting the template DNA to concentration gradient dilution, and then performing isothermal amplification by using the original concentrations, 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7 and 10-8 dilutions as templates, respectively, and observing the reaction results by electrophoresis, comparing the sensitivity of the L AMP method with that of the conventional PCR method, wherein the lowest detection limit of the PCR method is 47.5pg 475/. mu. L AMP method is 0.475 pg/. mu. L (FIG. 6), and the L AMP method established in the present test has higher sensitivity in detecting Klebsiella pneumoniae.
Wherein the meaning of each letter or number in fig. 6 is:
m is D L2000 DNA marker.
N is: and (5) negative control.
1 to 9 are reaction solutions with DNA concentrations of 475, 47.5, 4.75 × 10-1, 4.75 × 10-2, 4.75 × 10-3, 4.75 × 10-4, 4.75 × 10-5 and 4.75 × 10-6 ng/. mu. L, respectively.
The specific test result of the L AMP method provided by the embodiment of the invention is as follows:
referring to fig. 7 and table 1, different kinds of standard strains were inoculated on MH plates, and DNA template solutions were prepared by picking up after overnight in an incubator, respectively, and the results of the detection showed that no other bacteria except high virulence klebsiella pneumoniae could be amplified, as shown in fig. 7 and table 1. Tests prove that the detection method has good specificity and good detection effect when being used for detection.
As shown in FIG. 7, after each strain of Klebsiella pneumoniae was amplified, the product was subjected to gel electrophoresis, and a band of the specifically amplified product was observed. Wherein 1 is a positive control; strains 2 to 16 correspond to Table 1, respectively.
In addition, each common non-virulent Klebsiella pneumoniae amplification product can be observed by naked eyes to be transparent dark orange. Wherein 1 is a positive control; 2-16 strains are shown in Table 1
TABLE 1 specificity test of the 1L AMP method
The detection result of the L AMP method provided by the embodiment of the invention on clinical specimens is as follows:
referring to FIG. 8 and Table 2, using 15 strains of highly virulent Klebsiella pneumoniae genomic DNA such as AY9630, AY9293, AY8972, AY4992, AY4970, AY2075, AY11489, AP2841, JDZK01, GZK01, GZK02, GZK03, GZK20, XY1298, AP15127 and the like as templates, respectively, L AMP amplification, agarose gel electrophoresis (FIG. 8) and direct visual observation are performed on test strains, and results are observed and detected.
As shown in FIG. 8, after each high-virulence Klebsiella pneumoniae is amplified, the product thereof is subjected to gel electrophoresis, and a product band of specific amplification can be seen. l, AY 9630; 2, AY 9293; 3, AY 8972; 4, AY 4992; 5, AY 4970; 6, AY 2075; 7, AY 11489; 8, AP 2841; 9, JDZK 01; 10, GZK 01; 11, GZK 02; 12, GZK 03; 13, GZK 20; 14, XY 1298; 15, AP 15127.
In addition, human eye observation shows that the high-toxicity Klebsiella pneumoniae amplified products of all the strains present characteristic bright green compared with negative control.
TABLE 2 results of clinical strain testing of 2L AMP method
The above-mentioned embodiments are only used for illustrating the technical solutions of the present invention, and not for limiting the same; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; such modifications and substitutions do not substantially depart from the spirit and scope of the embodiments of the present invention, and are intended to be included within the scope of the present invention.
Claims (10)
1. A detection method for rapidly detecting Klebsiella pneumoniae with high toxicity is characterized by comprising the following steps:
extracting strain DNA;
placing the extracted strain DNA and the primer into a reaction solution to carry out L AMP amplification reaction;
the reaction solution comprises a primer, and the primer comprises:
the upstream outer primer F3: 5'-TGGGGTTATTCTTTCGCT-3', respectively;
downstream outer primer B3: 5'-TTTCCAAGCTTACTGCAATT-3', respectively;
an upstream inner primer FIP: 5'
-CCagCAAAacAGCCTAAATACATTG-TGGGGAGTATCTTTGAGAGG-3’;
The downstream inner primer BIP: 5'
-TTGGGATACTGTGCTATTTTTCTCT-GGGAAGATGAGAAATACGAGC-3’;
An upstream loop primer L F: 5'-CGCCTCCGTGATGAGGATG-3';
downstream loop primer L B: 5'-GCAGAAAAGGGCTAGCGC-3';
l after the AMP amplification reaction is finished, the reaction solution is tested to determine whether there is Klebsiella pneumoniae with high toxicity.
2. The method for rapidly detecting Klebsiella pneumoniae with high virulence according to claim 1, wherein the method for extracting the DNA of the strain comprises:
experimental bacteria were inoculated on MH agar plates and cultured overnight in an incubator at 37 ℃;
scraping appropriate amount of bacteria from MH agar plate, placing in 500ul of EP tube containing autoclaved double distilled water, and boiling in water bath for 10 min;
cooling in refrigerator for 10 min;
centrifuging at 12000g for 10min at 4 deg.C, and collecting supernatant.
3. The method for rapidly detecting Klebsiella pneumoniae with high virulence according to claim 1, wherein the mixture of the reaction solution is configured as follows:
12.5 μ L2 × HNB L AMP;
2.5 μ L10 ×L AMP primer mix;
0.8M betaine;
1.0 μ L Bst DNA polymerase;
1 μ L template DNA;
25 μ L sterile water.
4. The method for rapidly detecting Klebsiella pneumoniae with high virulence according to claim 3, wherein the concentration of the primer mixture of 2.5 μ L10 and 10 ×L AMP is configured as follows:
the concentrations of the upstream outer primer F3 and the downstream outer primer B3 are respectively as follows: 0.5 uM;
the concentrations of the upstream inner primer FIP and the downstream inner primer BIP are respectively as follows: 8 uM;
the concentration of the upstream loop primer L F and the downstream loop primer L B was 2uM, respectively.
5. The method for rapidly detecting Klebsiella pneumoniae with high virulence according to claim 4, wherein the reaction conditions of the L AMP amplification reaction are as follows:
placing the mixed solution of L AMP amplification reaction in a water bath environment;
the reaction temperature is as follows: a gradient is formed at every 5 ℃ between 55 and 85 ℃;
the reaction time is as follows: and gradient every 5min for 40-70 min.
6. The method for rapidly detecting Klebsiella pneumoniae with high virulence according to claim 5, wherein the reaction conditions of the L AMP amplification reaction are as follows:
the reaction temperature is as follows: 65 ℃;
the reaction time is as follows: 60 min;
the termination reaction temperature was: 85 ℃;
the reaction termination time was: and 5 min.
7. The method for rapidly detecting Klebsiella pneumoniae with high virulence according to any one of claims 1-6, wherein the step of detecting the reaction result to determine whether Klebsiella pneumoniae with high virulence exists comprises:
taking reaction liquid, detecting an amplification result by using agarose gel electrophoresis, if a gradient band is positioned and the minimum band is 180bp, indicating that the Klebsiella pneumoniae with high toxicity exists, and if not, indicating that the Klebsiella pneumoniae with high toxicity does not exist;
or adding SYBR green I into the reaction liquid for fluorescence detection, if the reaction liquid is green, indicating that the high-toxicity Klebsiella pneumoniae exists, otherwise, indicating that the high-toxicity Klebsiella pneumoniae does not exist.
8. A detection kit for rapidly detecting high-toxicity Klebsiella pneumoniae is characterized by comprising:
l AMP amplification reaction liquid, wherein the L AMP amplification reaction liquid contains primers which are respectively:
the upstream outer primer F3: 5'-TGGGGTTATTCTTTCGCT-3', respectively;
downstream outer primer B3: 5'-TTTCCAAGCTTACTGCAATT-3', respectively;
an upstream inner primer FIP: 5'
-CCagCAAAacAGCCTAAATACATTG-TGGGGAGTATCTTTGAGAGG-3’;
The downstream inner primer BIP: 5'
-TTGGGATACTGTGCTATTTTTCTCT-GGGAAGATGAGAAATACGAGC-3’;
An upstream loop primer L F: 5'-CGCCTCCGTGATGAGGATG-3';
the downstream loop primer L B: 5'-GCAGAAAAGGGCTAGCGC-3'.
9. The detection kit for rapidly detecting klebsiella pneumoniae with high virulence according to claim 8, wherein the mixture of the reaction solution is configured as follows:
12.5 μ L2 × HNB L AMP;
2.5 μ L10 ×L AMP primer mix;
0.8M betaine;
1.0 μ L Bst DNA polymerase;
1 μ L template DNA;
25 μ L sterile water.
10. The detection kit for rapidly detecting klebsiella pneumoniae with high virulence according to claim 9, wherein the concentration of the 2.5 μ L10 ×L AMP primer mixture is configured as follows:
the concentrations of the upstream outer primer F3 and the downstream outer primer B3 are respectively as follows: 0.5 uM;
the concentrations of the upstream inner primer FIP and the downstream inner primer BIP are respectively as follows: 8 uM;
the concentration of the upstream loop primer L F and the downstream loop primer L B was 2uM, respectively.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010278740.7A CN111500751B (en) | 2020-04-10 | 2020-04-10 | Detection method and kit for rapidly detecting high-virulence klebsiella pneumoniae |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010278740.7A CN111500751B (en) | 2020-04-10 | 2020-04-10 | Detection method and kit for rapidly detecting high-virulence klebsiella pneumoniae |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111500751A true CN111500751A (en) | 2020-08-07 |
CN111500751B CN111500751B (en) | 2023-10-27 |
Family
ID=71869204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010278740.7A Active CN111500751B (en) | 2020-04-10 | 2020-04-10 | Detection method and kit for rapidly detecting high-virulence klebsiella pneumoniae |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111500751B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112430677A (en) * | 2020-12-15 | 2021-03-02 | 深圳市第三人民医院 | Kit for identifying toxicity of Klebsiella pneumoniae and drug resistance of carbapenemase |
CN116083608A (en) * | 2022-11-04 | 2023-05-09 | 四川大学华西医院 | Kit and method for identifying klebsiella pneumoniae and detecting drug resistance and virulence of klebsiella pneumoniae |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104328174A (en) * | 2014-10-27 | 2015-02-04 | 中国人民解放军第四军医大学 | LAMP (loop-mediated isothermal amplification) primers, kit and method for detecting murine klebsiella pneumoniae |
CN104328175A (en) * | 2014-10-27 | 2015-02-04 | 中国人民解放军第四军医大学 | Loop-mediated isothermal amplification (LAMP) primers, kit and method for detecting mouse Klebsiella pneumoniae |
CN107365869A (en) * | 2017-09-08 | 2017-11-21 | 江苏农林职业技术学院 | The method and primer of food-borne Klebsiella Pneumoniae are detected using loop-mediated isothermal amplification technique |
CN108531629A (en) * | 2018-05-31 | 2018-09-14 | 广西壮族自治区兽医研究所 | A kind of PCR amplification primer of quick detection Friedlander's bacillus and its application |
CN110079622A (en) * | 2019-04-30 | 2019-08-02 | 南京广方生物科技有限公司 | Kit based on LAMP method detection Klebsiella Pneumoniae |
CN110669852A (en) * | 2019-11-04 | 2020-01-10 | 深圳市人民医院 | Kit for detecting high-toxicity non-mucus Klebsiella pneumoniae |
-
2020
- 2020-04-10 CN CN202010278740.7A patent/CN111500751B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104328174A (en) * | 2014-10-27 | 2015-02-04 | 中国人民解放军第四军医大学 | LAMP (loop-mediated isothermal amplification) primers, kit and method for detecting murine klebsiella pneumoniae |
CN104328175A (en) * | 2014-10-27 | 2015-02-04 | 中国人民解放军第四军医大学 | Loop-mediated isothermal amplification (LAMP) primers, kit and method for detecting mouse Klebsiella pneumoniae |
CN107365869A (en) * | 2017-09-08 | 2017-11-21 | 江苏农林职业技术学院 | The method and primer of food-borne Klebsiella Pneumoniae are detected using loop-mediated isothermal amplification technique |
CN108531629A (en) * | 2018-05-31 | 2018-09-14 | 广西壮族自治区兽医研究所 | A kind of PCR amplification primer of quick detection Friedlander's bacillus and its application |
CN110079622A (en) * | 2019-04-30 | 2019-08-02 | 南京广方生物科技有限公司 | Kit based on LAMP method detection Klebsiella Pneumoniae |
CN110669852A (en) * | 2019-11-04 | 2020-01-10 | 深圳市人民医院 | Kit for detecting high-toxicity non-mucus Klebsiella pneumoniae |
Non-Patent Citations (2)
Title |
---|
THOMAS A. RUSSO 等: "Identification of Biomarkers for Differentiation ofHypervirulent Klebsiella pneumoniae from ClassicalK. pneumoniae" * |
徐云明;魏利斌;周?M扬;李叶辉;孙智远;仲思远;陈爱宁;郭丽娟;柳增善;任洪林;: "肺炎克雷伯菌环介导等温扩增技术检测方法的建立" * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112430677A (en) * | 2020-12-15 | 2021-03-02 | 深圳市第三人民医院 | Kit for identifying toxicity of Klebsiella pneumoniae and drug resistance of carbapenemase |
CN116083608A (en) * | 2022-11-04 | 2023-05-09 | 四川大学华西医院 | Kit and method for identifying klebsiella pneumoniae and detecting drug resistance and virulence of klebsiella pneumoniae |
Also Published As
Publication number | Publication date |
---|---|
CN111500751B (en) | 2023-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | Evaluation of Seeplex® STD6 ACE Detection kit for the diagnosis of six bacterial sexually transmitted infections | |
CN107022644A (en) | Six kinds of multiple LAMP detection primers of food-borne pathogens, detection kit and detection method in fruits and vegetables | |
US20100075306A1 (en) | Method for diagnosis of and following a bacterial vaginosis by molecular quantification | |
CN103866034A (en) | Multiple real-time fluorescence quantification PCR (polymerase chain reaction) detection kit and detection method for helicobacter pylori in gastric juice | |
Kurupati et al. | Rapid detection of Klebsiella pneumoniae from blood culture bottles by real-time PCR | |
CN105063218B (en) | The multiple quantitative PCR reagent kit of the difficult culture identification bacterium of four kinds of fast joint inspection | |
Wang et al. | Rapid and sensitive recombinase polymerase amplification combined with lateral flow strips for detecting Candida albicans | |
Shipitsyna et al. | Evaluation of polymerase chain reaction assays for the diagnosis of Trichomonas vaginalis infection in Russia | |
CN112852984B (en) | Detection system for urinary system infection pathogen, kit and application thereof | |
CN102816847A (en) | LAMP primer for detecting Brucella and kit containing the same | |
CN105779625B (en) | It is a kind of to detect that Streptococcus suis is universal and streptococcus suis 2-type double fluorescent quantitative PCR primer, kit and method simultaneously | |
CN101113473A (en) | Method for detecting food-derived pathogenic vibrio bacteria by composite fluorescence PCR technique | |
CN109234419A (en) | Bacillus anthracis double fluorescent quantitative PCR detection kit and detection method | |
CN111440886A (en) | Primer group, kit and detection method for rapidly detecting carbapenemase gene | |
CN109280711A (en) | LAMP detection primer group, detection kit and its detection method of mycobacterium kansasii | |
CN111500751A (en) | Detection method and kit for rapidly detecting high-toxicity Klebsiella pneumoniae | |
Xin et al. | Rapid detection and differentiating of the predominant Salmonella serovars in chicken farm by TaqMan multiplex real-time PCR assay | |
Cherkaoui et al. | Development and validation of a modified broad-range 16S rDNA PCR for diagnostic purposes in clinical microbiology | |
ITVT20110002A1 (en) | METHOD OF DETERMINING THE ORIGIN OF FLUIDS OR BIOLOGICAL TRACKS AND REAGENT KITS FOR THEIR IDENTIFICATION IN A SAMPLE. | |
CN108866164A (en) | The streptococcic detection method of B race and kit | |
CN102154487A (en) | Reagent for detecting francisella tularensis and complex probe and fluorescent quantitative polymerase chain reaction (PCR) method for detecting francisella tularensis | |
Öncül et al. | Detecting gram-positive anaerobic cocci directly from the clinical samples by multiplex polymerase chain reaction in odontogenic infections | |
CN102312013B (en) | Primers and probes for detecting 89K pathogenicity island genes of Streptococcus suis serotype 2, real-time fluorescence quantitative PCR method and kit thereof | |
CN115747361A (en) | Real-time fluorescent MIRA and MIRA-LFD primer group for detecting streptococcus iniae and detection method | |
CN116121413A (en) | Real-time fluorescent nucleic acid isothermal amplification detection kit for group B streptococcus and special primer and probe thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |